Summary & Overview
HCPCS G2115: Frailty with Dispensed Dementia Medication, Ages 66–80
HCPCS Level II code G2115 denotes patients aged 66–80 with at least one encounter for frailty during the measurement period and a dispensed dementia medication during the measurement period or the prior year. The code supports identification and tracking of a clinically vulnerable older population at the intersection of frailty and dementia treatment. Nationally, this code matters for population health monitoring, quality measures, and care coordination for older adults with cognitive impairment and frailty, given the potential implications for medication safety, care transitions, and advanced care planning.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks and national-level context for the use of G2115, summaries of payer coverage considerations, and clinical context related to frailty and dementia medication dispensing. The publication also outlines policy updates and coding guidance that affect how this population is identified in claims data, and it highlights implications for outpatient and ambulatory care workflows. Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, related codes, and service line are noted where applicable.
Billing Code Overview
HCPCS Level II code G2115 identifies patients aged 66 to 80 years who have at least one claim or encounter for frailty during the measurement period and who have a dispensed medication for dementia during the measurement period or in the year prior. The service type reflected by this code is clinical population identification / chronic condition medication reconciliation, focused on older adults with coexisting frailty and dementia medication use. The typical site of service is ambulatory care or outpatient clinic settings where encounters and medication dispensing are recorded, including primary care clinics, geriatrics clinics, memory disorder centers, and outpatient pharmacy records.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an older adult between 66 and 80 years of age with documented frailty and a recent or ongoing dispensed medication for dementia (for example, donepezil, rivastigmine, galantamine, or memantine) during the measurement period or in the year prior. The clinical workflow begins in primary care, geriatrics, or neurology where the patient presents for routine follow-up or care coordination. Frailty identification may occur through frailty screening (clinical frailty scale, gait speed, weight loss, exhaustion, or clinician documentation) recorded as a claim or encounter. Medication reconciliation confirms a dispensed dementia medication within the specified timeframe. The clinician documents frailty and reviews the dementia medication list in the electronic health record, ensuring pharmacy fill history supports the claim. Coding staff then assign the HCPCS Level II code G2115 on the claim to indicate the patient meets the measure: age 66–80, a frailty encounter, and a dispensed dementia medication during the measurement period or prior year. Typical sites of service include primary care clinics, geriatric clinics, neurology outpatient practices, home health visits, and long-term care or assisted living facility encounters where medication administration and frailty assessments are documented.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |